These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2465188)

  • 41. [Nuclear DNA content of thyroid adenocarcinoma].
    Yoshida A
    Nihon Geka Gakkai Zasshi; 1984 Oct; 85(10):1261-73. PubMed ID: 6503946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Results of combined modality treatment in poorly differentiated and anaplastic thyroid carcinoma.
    Auersperg M; Us-Krasovec M; Petric G; Pogacnik A; Besic N
    Wien Klin Wochenschr; 1990 Apr; 102(9):267-70. PubMed ID: 2375116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship among 201T1 uptake, nuclear DNA content and clinical behavior in metastatic thyroid carcinoma.
    Nakada K; Katoh C; Morita K; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Tamaki N
    J Nucl Med; 1999 Jun; 40(6):963-7. PubMed ID: 10452311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The growth activity and DNA ploidy in anaplastic carcinoma transplanted to nude mice].
    Yoshida A; Asaga T; Masuzawa C; Kawahara S; Yanoma S; Shimizu A; Harada M
    Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):177-81. PubMed ID: 8464414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation.
    Amacher AM; Goyal B; Lewis JS; El-Mofty SK; Chernock RD
    Am J Surg Pathol; 2015 Feb; 39(2):260-5. PubMed ID: 25321328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers.
    Pannone G; Santoro A; Pasquali D; Zamparese R; Mattoni M; Russo G; Landriscina M; Piscazzi A; Toti P; Cignarelli M; Lo Muzio L; Bufo P
    Thyroid; 2014 Mar; 24(3):511-9. PubMed ID: 24117205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA measurements on cell nuclei of normal, proliferating and neoplastic thyroid tissues in rats.
    Christov K; Thomas C; Sandritter W
    Neoplasma; 1975; 22(3):285-94. PubMed ID: 1161121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma.
    Shattuck TM; Westra WH; Ladenson PW; Arnold A
    N Engl J Med; 2005 Jun; 352(23):2406-12. PubMed ID: 15944425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationships between the Ga-67 uptake and nuclear DNA Feulgen content in thyroid tumors: concise communication.
    Higashi T; Watanabe Y; Yamaguchi M; Hisada T; Mimura T; Ito K; Allison JR
    J Nucl Med; 1982 Nov; 23(11):988-92. PubMed ID: 7131088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid.
    Hunt JL; Tometsko M; LiVolsi VA; Swalsky P; Finkelstein SD; Barnes EL
    Am J Surg Pathol; 2003 Dec; 27(12):1559-64. PubMed ID: 14657716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anaplastic transformation of medullary thyroid cancer.
    Zeman V; Nĕmec J; Platil A; Zamrazil V; Pohunková D; Neradilová M
    Neoplasma; 1978; 25(2):249-55. PubMed ID: 643127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA ploidy in papillary tumours of the breast.
    Tiltman AJ
    S Afr Med J; 1989 Apr; 75(8):379-80. PubMed ID: 2711268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The multiplicity of thyroid nodules and carcinomas.
    Utiger RD
    N Engl J Med; 2005 Jun; 352(23):2376-8. PubMed ID: 15944422
    [No Abstract]   [Full Text] [Related]  

  • 54. DNA ploidy and stromal bone formation as prognostic indicators of thyroid papillary carcinoma in aged patients: a retrospective study.
    Yamashita H; Noguchi S; Murakami N; Tsuji K; Yamaoka N; Sakamoto A
    Acta Pathol Jpn; 1993; 43(1-2):22-7. PubMed ID: 8465653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Flow cytometric DNA analysis of thyroid carcinoma.
    Tsuchiya A; Sekikawa K; Ando Y; Suzuki S; Kimijima I; Abe R
    Jpn J Surg; 1990 Sep; 20(5):510-4. PubMed ID: 2243443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [An immunohistochemical study of estrogen receptors in thyroid carcinoma].
    Haruta R; Ito H; Takeichi N; Matsuyama T; Dohi K; Tahara E
    Gan No Rinsho; 1990 Mar; 36(4):465-8. PubMed ID: 2181164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The biological classifications of malignant thyroid tumours (author's transl)].
    Kokoschka R; Roka R; Depisch D; Aiginger P; Weissel M; Kolbe H; Krisch K
    Wien Klin Wochenschr; 1979 Sep; 91(18):605-10. PubMed ID: 483824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fatal thyroid carcinoma. Anaplastic transformation of adenocarcinoma.
    Harada T; Ito K; Shimaoka K; Hosoda Y; Yakumaru K
    Cancer; 1977 Jun; 39(6):2588-96. PubMed ID: 872057
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nuclear DNA content of the tall cell variant of papillary carcinoma of the thyroid gland.
    Stern Y; Medelia O; Feinmesser M; Shpitzer T; Feinmesser R; Segal K
    Ann Otol Rhinol Laryngol; 1996 Sep; 105(9):713-5. PubMed ID: 8800058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of nuclear DNA content in locally invasive and noninvasive papillary carcinoma of the thyroid gland.
    Stern Y; Lisnyansky I; Shpitzer T; Nativ O; Medalia O; Feinmesser R; Aronson M
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):501-3. PubMed ID: 9374174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.